Targeting MCP-1 using overexpression of a mutant form of MCP-1, accordingly, attenuates pulmonary fibrosis induced by bleomycin in C57BL/6 mice (Inoshima et al., 2004). This evidence concerns the gene CCL2 and pulmonary fibrosis.